Aims & Scope
iMed dedicates to publishing rigorously peer-reviewed high-quality content, including original research articles, cutting-edge review articles, clinical trial reports, commentaries, and perspective articles, focused on significant advancements in fundamental, translational, and clinical medical research. Areas that are covered include but are not limited to:
- Radiation Medicine and Science: Radiobiology; Radioprotection; Radiation Toxicology; Radiation Epidemiology; Radiotherapy (including novel techniques such as FLASH, Proton and Heavy-Ion Radiotherapy); Nuclear Medicine; Radiomics.
- Oncology Science: Cancer Biology; Tumorigenesis and Development; Tumor Microenvironment; Cancer Metabolism; Tumor Metastasis and Therapeutic Resistance; Cancer-Specific Experimental Animal Models.
- Therapeutic Strategies and Drug Development: Chemotherapy and Targeted Therapy; Immunotherapy; Gene Therapy; Cell Therapy; Preclinical and Clinical Drug Development; Nanodrugs; Intelligent Drug Delivery Systems; Antibody-Drug Conjugates (ADCs).
- Medical Imaging and Intervention: Radiology; Molecular Imaging; Multi-modality Image Fusion; Interventional Radiology; Image-Guided Therapy.
- Frontier Interdisciplinary Disciplines: AI-Empowered Medicine; Medical Big Data Analytics and Real-World Evidence; System Biology; Multi-Omics Technologies; Organoids and Organ-on-a-Chip Technologies.
- Basic Medicine and Biology: Molecular and Cellular Biology; Cell Fate Determination; Mutagenesis and Evolution; Aging Biology; Immunology; Stem Cell Biology; Regenerative Medicine.
- Public Health and Special Environmental Biology: Public Health and Preventive Medicine; Epidemiology; Space Biology; Underground Biology; Special Medicine.
- Broad Clinical Disciplines: Significant clinical and translational research in areas such as Neuroscience, Cardiovascular Medicine, and Metabolic Diseases.